Midweek Biopharma Update - $BLRX $PATH $NEPT and others + Twitter bashers commentary. YouTube Video, enjoy!
Post navigation
3 thoughts on “Midweek Biopharma Update – $BLRX $PATH $NEPT and others + Twitter bashers (Video)”
Leave a Reply
You must be logged in to post a comment.
Great video Scott.
I’m trying to learn chart reading myself.
“anti business socialist” Exactly… ! Great video Scott!
That being said, got a q for you: what’s the deal with Amicus? Do you think its a buy at sub 4’s? thanks, FDS
I do think it’s a spec buy as I think the so called ” failed” 6 month 011 data was a control issue, possible concerning asymptomatic females. The company in their pr’s seems to hint they believe its a control issue as they have said ” we plan to seek approval” and not saying ” we will confer with GSK Am,how to proceed with Amigal.